Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer

Triple-negative breast cancer accounts for approximately 15% of all diagnosed breast cancers and is charac­terized by an aggressive clinical course resulting from rapid proliferation of tumor cells poses a huge therapeutic challenge. The shortened, in comparison with other subtypes of breast cancer,...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Tomasz Kubiatowski, Ewa Kalinka
Format:	Artigo
Sprog:	Inglês
Udgivet:	Termedia Publishing House 2025-10-01
Serier:	Menopause Review
Fag:	triple negative breast cancer adc sacituzumab govitecan datopotamab deruxtecan trastu­zumab deruxtecan.
Online adgang:	https://www.termedia.pl/Antibody-drug-conjugates-in-the-treatment-of-advanced-triple-negative-breast-cancer,4,56819,1,1.html
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!